UWM
MBIO icon

Urban Wealth Management’s Mustang Bio MBIO Stock Holding History

Urban Wealth Management’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$13K Buy
+29
New +$16.1K 0.04% 184

Other funds holding MBIO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

Urban Wealth Management's MBIO Position: Q2 2022 in Review

Urban Wealth Management opened a new position in Mustang Bio (MBIO) in Q2 2022: 29 shares worth $13K. The stake represents 0.04% of the portfolio and ranks #184 among its holdings.

71 funds tracked by Wall St. Rank hold MBIO as of Q2 2022.

  • Urban Wealth Management held 29 shares of Mustang Bio worth $13K as of Q2 2022.
  • Mustang Bio was a new Urban Wealth Management position in Q2 2022.
  • Mustang Bio made up 0.04% of Urban Wealth Management's portfolio in Q2 2022, its #184 holding.
  • 71 funds tracked by Wall St. Rank held Mustang Bio as of Q2 2022.

Based on Urban Wealth Management's 13F filing for Q2 2022, filed 22 Jul 2022.